The effect of tinidazole for treatment and recurrence of bacterial vaginosis

Phase 2

• Conditions: Acute vaginitis; Bacterial vaginosis.

• Registration Number: IRCT2012073110457N1
• Lead Sponsor: Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 110

Inclusion Criteria

age 45-15 years, married women, diagnosis of bacterial vaginosis by clinical signs and diagnostic tests, accept the use of condoms during treatment. Exclusion criteria: associated with Candida vaginitis and trichomonas, Pregnancy, consume antibiotics at the same time or within two weeks and using the vaginal cream, metronidazole used simultaneously to any cause, having a chronic disease and diabetes, Immunosuppression or immune-lowering medication use, having cervicitis, chronic bacterial vaginosis

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Vaginal discharge. Timepoint: Pre intervention, two and four weeks after treatment. Method of measurement: Observation.;Vaginal PH. Timepoint: Pre intervention.two and four weeks after treatment. Method of measurement: Universal indicator paper.;Wiff test. Timepoint: Pre intervention,two and four weeks after treatment. Method of measurement: KOH.;Clue cell. Timepoint: Pre intervention, two and four weeks after treatment. Method of measurement: Pap smear.